Veterinary APIs Market Overview: Cost Pressures and Post-Holiday Price Adjustments

The veterinary APIs market is currently stable, although there are varying trends across different categories. In early February, prior to the Spring Festival, market sentiment was weak, leading to lighter transaction volumes. Following the holiday, the price of mequindox has seen an upward trend, supported by stronger cost-side factors. Manufacturers of amoxicillin have maintained firm pricing, while the market displays a strong wait-and-see attitude. Categories such as doxycycline hyclate, florfenicol, and tylosin tartrate have experienced volatile price consolidations.

It is important to note that many enterprises are not expected to resume normal production and operations until after the Lantern Festival on March 3rd, indicating that the current market does not yet fully reflect the dynamics of the industry.

Prior to the Spring Festival, major mainstream manufacturers suspended quotations, leaving very limited room for further declines, and prices rebounded slightly from the bottom. Post-holiday market conditions have been stable, with prices basically flat compared to the pre-Spring Festival level. The market price index for this period is experiencing bottom volatility. In the short term, due to factors such as costs, demand, and peer competition, market prices are not expected to undergo significant changes.

Influenced by raw material costs, manufacturers' quotations remain firm after the Chinese New Year, with some manufacturers quoting delivery dates in April. There are few low-priced goods in the market, and prices are trending strong. It is recommended to monitor market demand and manufacturer supply situations.

On February 11th, the average market price of Doxycycline Hcl is 313 yuan/kg, indicating a phase of bottom volatility. Before the Spring Festival holiday, several mainstream manufacturers suspended quotations, leading to a tightening of supply, with some explicitly communicating inventory strain to the market. This situation on the supply side seems to be gaining momentum, potentially setting the stage for price increases after the holiday. End-users are advised to develop procurement plans based on their actual demand.

On the 11th, the average market price for Tilmicosin was 349 yuan/kg, representing a decline of 4.38% since the beginning of this year. Currently, major manufacturers are maintaining a firm pricing strategy. Although market demand has weakened, there are signs of stabilization. Inventory transactions are seeing limited price negotiations. The market is expected to continue its volatile consolidation trend in the near future.

Key observations include: - The market for VD3, VB2 80%, and B12 is facing sluggish trading and weak consolidation. - Some manufacturers of 2% Biotin have suspended their quotations. - VB6 production capacity is gradually being released, contributing to a weakening market consolidation. - Major Nicotinamide manufacturers have not yet provided clear quotations following the holiday.
Additionally, the combination of pre-holiday raw material price increases and ongoing tight delivery schedules has led to strong bullish expectations within the market.

Maintain vitamin A manufacturers have suspended quotations, while downstream players remain in a wait-and-see mode, keeping market prices stable for now.

Driven by production halts and quotation suspensions from major manufacturers, the overall market inventory is currently low, leading to a modestly firming price trend.

ZMC Changhai plant plans to suspend production for approximately four weeks starting from early February.

Market activity has been subdued in recent days, with prices stabilizing within a narrow range.

Due to rising raw material costs, some manufacturers have suspended quotations and adopted a firm pricing stance, leading to a slight increase in market transactions.

The post-Chinese New Year vitamin market is currently experiencing temporary stability, with participants adopting a wait-and-see approach.

Market sentiment following the Spring Festival holiday remains cautious. Mainstream quotes across various categories are holding steady, and transactions are sporadic. In the lysine market, manufacturers are quoting firmly, with some suspending quotations and others tentatively raising prices. The methionine market sees manufacturers prioritizing the fulfillment of earlier orders. In the threonine market, both upstream and downstream players are cautiously observing, resulting in subdued market inquiries and transactions.

On February 13, the European Commission issued Implementing Regulation (EU) 2026/319, making a final affirmative anti-dumping determination regarding valine products originating in China and officially imposing anti-dumping duties on the products involved. 

For more details, click here.